MEDICAL SYSTEM NETWORK Co., Ltd. is mainly engaged in the operation of dispensing pharmacy business. The Company operates in five business segments. The Pharmaceutical Product Network segment involves in ordering system of medicines, development and sale of systems, and support services for securitized receivables. The Dispensing Pharmacy segment operates and manages dispensing pharmacies. The Leasing and Equipment-related Business segment involves in the location development of pharmacies, the rental of buildings for clinics, and the operation of buildings and housing for the elderly. The Food Supply segments provides food service within hospitals and welfare facilities. The Others segment involves in clinical trial support services and visiting nursing services.

Employees

Sector

Drug Retailers

Calendar

Earnings release - Q1 2027

More about the company

Income Statement and Estimates

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

02-06	Medical System Network Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2025	CI
11-07	Medical System Network Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2025, Payable on December 8, 2025	CI

Market Cap	13.83B 85.72M 74.94M 68.87M 64.19M 122M 8.16B 124M 827M 321M 4.01B 322M 315M	P/E 2025	9.1x	P/E 2026	14.8x
Enterprise Value	43.75B 271M 237M 218M 203M 385M 25.83B 391M 2.62B 1.02B 12.7B 1.02B 996M	EV / Sales 2025	0.27x	EV / Sales 2026	0.35x
Free-Float	55.45%	Yield 2025	3.05%	Yield 2026	2.22%

02-06	Medical System Network Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2025	CI
11-07	Medical System Network Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2025, Payable on December 8, 2025	CI
25-05-09	Medical System Network Co., Ltd. Announces the Dividend for the Year Ended March 31, 2025, Payable on June 25, 2025; Provides Dividend Guidance for the Second Quarter and for the Year Ending March 31, 2026	CI
25-05-09	Medical System Network Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and for Full Year of the Fiscal Year Ending March 31, 2026	CI
24-12-22	PHARUMO, Inc. announced that it expects to receive ¥500 million in funding from Medical System Network Co., Ltd.	CI
24-11-08	Medical System Network Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending March 31, 2025	CI
24-11-08	Medical System Network Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 9, 2024	CI
24-08-07	Medical System Network Co., Ltd. Provides Dividend Guidance for the Full Year Ending March 31, 2024 and Provides Dividend Guidance for the Fiscal Year Ending March 31, 2025	CI
24-08-07	Medical System Network Co., Ltd. Provides Consolidated Earnings Guidance for First Half and for Full Year of Fiscal Year Ending March 31, 2025	CI
24-02-18	Tranche Update on Medical System Network Co., Ltd.'s Equity Buyback Plan announced on February 16, 2024.	CI
24-02-18	Medical System Network Co., Ltd.'s Equity Buyback announced on February 16, 2024, has closed with 950,000 shares, representing 3.15% for ¥555.75 million.	CI
24-02-16	Medical System Network Co., Ltd. announces an Equity Buyback for 950,000 shares, for ¥555.75 million.	CI
24-02-15	Medical System Network Co., Ltd. authorizes a Buyback Plan.	CI

22-02-04	Medical System Network : Consolidated Financial Results for the Nine Months Ended December 31, 2021 (Japanese GAAP)	PU
21-11-05	Consolidated Financial Results for the Six Months Ended September 30, 2021 (Japanese GAAP)	PU

Medical System Network Co., Ltd. Stock OTC Markets

Stocks

MSYMF

JP3920940008

Drug Retailers

Valuation: Medical System Network Co., Ltd.

Latest news : Medical System Network Co., Ltd.

Press Releases: Medical System Network Co., Ltd.

Managers and Directors: Medical System Network Co., Ltd.

Other Drug Retailers

Financials

Company Profile

Income Statement and Estimates

Quarterly revenue - Rate of surprise

Manager	Title	Age	Since
Inao Tajiri PSD	President	78	1999-09-15
Eiji Hirashima DFI	Director of Finance/CFO	64	2021-06-23
Makoto Sakashita ADM	Chief Administrative Officer	69	2017-09-30

Director	Title	Age	Since
Inao Tajiri BRD	Director/Board Member	78	1999-09-15
Jiro Akino BRD	Director/Board Member	78	1999-09-15
Kazuhiko Sumi BRD	Director/Board Member	63	2000-08-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEDICAL SYSTEM NETWORK CO., LTD.	-.--%	-.--%	-	-	85.72M
JD HEALTH INTERNATIONAL INC.	+5.68%	+12.88%	-13.01%	-30.44%	14.7B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	+4.44%	+7.17%	-22.04%	-32.02%	6.78B
MATSUKIYOCOCOKARA & CO.	+0.71%	-0.62%	-18.59%	-9.74%	5.87B
YIFENG PHARMACY CHAIN CO., LTD.	+3.58%	+9.79%	-20.13%	-34.02%	3.57B
CLICKS GROUP LIMITED	+3.52%	+7.91%	-35.58%	-9.11%	3.44B
NAHDI MEDICAL COMPANY	+0.32%	0.00%	-27.97%	-44.96%	3.25B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+4.67%	+15.20%	+1.67%	-37.20%	2.86B
GUARDIAN PHARMACY SERVICES, INC.	-0.31%	-0.73%	+101.44%	-	2.66B
DIS-CHEM PHARMACIES LIMITED	-0.34%	-2.60%	+0.52%	+37.23%	1.72B
Average	+2.48%	+4.85%	-3.74%	-20.03%	4.98B
Weighted average by Cap.	+3.48%	+7.09%	-10.24%	-25.20%

	2025	2026
Net sales	122B 759M 663M 610M 568M 1.08B 72.25B 1.09B 7.32B 2.85B 35.52B 2.85B 2.79B	132B 820M 717M 658M 614M 1.16B 78.04B 1.18B 7.91B 3.07B 38.36B 3.08B 3.01B
Net income	1.26B 7.82M 6.84M 6.29M 5.86M 11.11M 745M 11.28M 75.47M 29.34M 366M 29.37M 28.74M	1.07B 6.63M 5.8M 5.33M 4.97M 9.42M 632M 9.57M 63.99M 24.88M 311M 24.9M 24.37M
Net Debt	21.33B 132M 116M 106M 99.03M 188M 12.59B 191M 1.28B 496M 6.19B 496M 486M	29.93B 186M 162M 149M 139M 264M 17.67B 268M 1.79B 696M 8.68B 696M 682M